Jakarta Post

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
The Jakarta Post 34
Video Weather icon 30°C
DKI Jakarta, Indonesia
30°C Partly Cloudy

Dry and mostly cloudy throughout the day.

  • Wed

    26℃ - 32℃

  • Thu

    25℃ - 32℃

  • Fri

    25℃ - 31℃

  • Sat

    26℃ - 30℃

Pharmaceutical convention CPhI targets over 5,000 visitors

  • Stefani Ribka
    Stefani Ribka

    The Jakarta Post

Jakarta | Fri, March 17, 2017 | 03:09 pm
Pharmaceutical convention CPhI targets over 5,000 visitors Drug prescription for treatment medication. Businesspeople and government officials have stated that they hope the raw material segment will further develop to cater to Indonesia’s more than 250-million-strong population. (Shutterstock/File)

The Convention on Pharmaceutical Ingredients Southeast Asia (CPhI SEA) 2017 hopes to see a 10 percent increase in the number of visitors to 5,200 during the event, which will take place in Jakarta from March 22 to 24.

The fourth CPhI SEA will also host an investment forum for the pharmaceutical sector for the first time, with around 50 investors invited.

“CPhI is a platform to gather various industrial players to build trust and explore potential markets, as well as exchange information and knowledge,” Ivan Ferrari, general manager of event organizer PT UBM Pameran Niaga Indonesia, said in a media briefing on Thursday.

(Read also: Indonesia to tackle unhealthy practices in health sector)

The value of Indonesia’s pharmaceutical market is expected to reach US$7 billion by 2025, from $5 billion today, according to Indonesia Pharmaceutical Materials Management Club and healthcare information and technology services company IMS Health.

At present, about 30 percent or $1.5 billion comes from the raw materials segment.

Businesspeople and government officials have stated that they hope the raw material segment will further develop to cater to Indonesia’s more than 250-million-strong population.

The National Board of the Indonesian Pharmaceutical Association (GPFI) claims that dependence on imported raw materials has worsened to 95 percent today from 80 percent in 2000 due to the lack of tariff barriers against imported ingredients, which were lifted in 1995 when Indonesia joined the World Trade Organization (WTO). (tas)

Join the discussions